User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

FXI concentrate use and risk of thrombosis

Primary tabs

Bolton-Maggs, P. Goudemand, J. Hermans, Cédric [UCL] Makris, M. de Moerloose, P.
Document type Article de périodique (Journal article) – Lettre à l'éditeur
Access type Accès restreint
Publication date 2014
Language Anglais
Journal information "Haemophilia" - Vol. 20, no. 4, p. e349-e351 (2014)
Peer reviewed yes
Publisher Wiley-Blackwell Publishing Ltd. ((United Kingdom) Oxford)
issn 1351-8216
e-issn 1365-2516
Publication status Publié
Affiliations UCL - SSS/IREC/CARD - Pôle de recherche cardiovasculaire
UCL - (SLuc) Service d'hématologie
UCL - (SLuc) Centre de malformations vasculaires congénitales
Links
  1. Bolton-Maggs P. H. B., Factor XI deficiency--resolving the enigma?, 10.1182/asheducation-2009.1.97
  2. PEYVANDI F., DI MICHELE D., BOLTON-MAGGS P. H. B., LEE C. A., TRIPODI A., SRIVASTAVA A., , Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity : Classification of rare bleeding disorders, 10.1111/j.1538-7836.2012.04844.x
  3. RUGERI L., QUÉLIN F., CHATARD B., DE MAZANCOURT P., NEGRIER C., DARGAUD Y., Thrombin generation in patients with factor XI deficiency and clinical bleeding risk : THROMBIN GENERATION IN FXI DEFICIENCY, 10.1111/j.1365-2516.2010.02246.x
  4. Guéguen Paul, Galinat Hubert, Blouch Marie-Thérèse, Bridey Françoise, Duchemin Jérôme, Le Gal Grégoire, Abgrall Jean-François, Pan-Petesch Brigitte, Biological determinants of bleeding in patients with heterozygous factor XI deficiency : Factor XI Deficiency and Bleeding Determinants, 10.1111/j.1365-2141.2011.08945.x
  5. Bolton-Maggs P.H.B, Colvin B.T, Satchi G, Lee C.A, Lucas G.S, Thrombogenic potential of factor XI concentrate, 10.1016/s0140-6736(94)92237-3
  6. Mannucci, Blood, 84, 1314 (1994)
  7. Bolton-Maggs P. H. B., Perry D. J., Chalmers E. A., Parapia L. A., Wilde J. T., Williams M. D., Collins P. W., Kitchen S., Dolan G., Mumford A. D., The rare coagulation disorders - review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation, 10.1111/j.1365-2516.2004.00944.x
  8. Livnat, Thromb Haemost, 102, 487 (2009)
  9. O'CONNELL N. M., RIDDELL A. F., PASCOE G., PERRY D. J., LEE C. A., Recombinant factor VIIa to prevent surgical bleeding in factor XI deficiency, 10.1111/j.1365-2516.2008.01663.x
  10. Roemisch JR Identification of activated FXI as the major biochemical root cause in IVIG batches associated with thromboembolic events http://webmedcentralcom/article_view/2002
Bibliographic reference Bolton-Maggs, P. ; Goudemand, J. ; Hermans, Cédric ; Makris, M. ; de Moerloose, P.. FXI concentrate use and risk of thrombosis. In: Haemophilia, Vol. 20, no. 4, p. e349-e351 (2014)
Permanent URL http://hdl.handle.net/2078.1/164284